Clinical Trial Update: Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating whether bridging with Coumadin vs. continuing anticoagulation around device surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematoma

Drugs mentioned

• Coumadin (warfarin)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Hematoma | Phase 4 | Status: TERMINATED